Suggestions

IDXX · NASDAQ

IDEXX LABORATORIES INC

Private beta

Sector unavailable · Industry unavailable

$504.70

-0.36%

Close on Sep 11, 2026

Defensively Qualified

Updated 6/30/2026

Long-term research evidence only. No price targets, no trading signals, no recommendations.

Investment Report Card

IDEXX LABORATORIES INC

Sector unavailable · Data confidence good

80 / 100

Rank #29 of 1,152 qualified companies

Top 5% · Worth a Closer Look

Risk Intelligence

Core Model
B

79 / 100

Fundamentally Qualified

How strong and defensively sound is the company?

Above average on this measure.

Long-Term Potential

Research Model
B

77 / 100

Weak Compounder

Does the business have the characteristics needed to create value over many years?

Above average on this measure.

Fundamental Momentum

Research Model
B−

72 / 100

Middle

Is the underlying business getting stronger or weaker?

Above average on this measure.

Ownership Intelligence

Supplemental Intelligence
C+

68 / 100

Positive disclosed activity

What are important owners actually doing?

Around the middle of the covered universe.

Valuation Intelligence

Research Model
C

65 / 100

Attractive

Is today's price reasonable?

Around the middle of the covered universe — and valuation is researched separately from the Suggested Investment Score.

Capital Returns Intelligence

Research Model
C

60 / 100

Favorable Capital Returns

How effectively does the company reward shareholders?

Around the middle of the covered universe — and capital returns are researched separately from the Suggested Investment Score.

Why it stands out

  • Business Quality meets the frozen IA Defensive qualification.
  • More disclosed holders are new or increasing than reducing or exiting.
  • Attractive valuation: the stock reads 65 out of 100 on Valuation Intelligence (Attractive) relative to its own history and comparable companies.

What holds it back

No weakening evidence is recorded in today's readings.

Long-term view

IDEXX LABORATORIES INC scores 77 on Long-Term Potential (B), described by the research model as weak compounder. This describes business characteristics only — it is not a forecast of future returns.

Ownership view

Disclosed ownership evidence reads 68 (C+): Positive disclosed activity. 5 tracked managers disclosed a position in the latest reporting period. Ownership filings are historical disclosures, not signals.

Valuation view

IDEXX LABORATORIES INC reads 65 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and above comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value. Valuation Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

Capital returns view

IDEXX LABORATORIES INC reads 60 out of 100 on Capital Returns Intelligence (Favorable Capital Returns), reflecting a share count falling about 1.8% a year. Direct capital returns are limited because the company continues reinvesting most of its cash. Capital Returns Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

What changed

No meaningful recorded changes in the stored history.

Risk Intelligence is a core model, Long-Term Potential, Fundamental Momentum, Valuation Intelligence and Capital Returns Intelligence are research models, and Ownership Intelligence is supplemental descriptive evidence. Valuation Intelligence and Capital Returns Intelligence each contribute 0% to the Suggested Investment Score. Nothing here is a recommendation.

Compare IDXX with other companies

Appears in

Rule-based membership

Membership means the company satisfied a published rule on the latest research build. It is not a recommendation.

About a minute to read

The 60-Second Investment Brief

Written from stored research readings only. No hype. No trading signals. Just better evidence.

Why it's interesting

IDEXX LABORATORIES INC (IDXX) scores 80 out of 100 and ranks #29 of 1,152 qualified companies today. That places it in the top 5% of ranked companies. The stored tier for that score is worth a closer look.

Business strength

Risk Intelligence reads 79 out of 100 (B), recorded as fundamentally qualified. Above average on this measure.

Long-term opportunity

Long-Term Potential reads 77 out of 100 (B), recorded as weak compounder. Above average on this measure.

What's improving or weakening

Fundamental Momentum reads 72 out of 100 (B−), recorded as middle. Above average on this measure.

What important owners are doing

Ownership Intelligence reads 68 out of 100 (C+), recorded as positive disclosed activity. Around the middle of the covered universe.

What kind of price you'd be paying

Valuation currently appears favourable: Valuation Intelligence reads 65 out of 100 (C), recorded as Attractive. IDEXX LABORATORIES INC reads 65 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and above comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value. Valuation Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

How the company rewards shareholders

Capital Returns Intelligence reads 60 out of 100 (C), recorded as Favorable Capital Returns. IDEXX LABORATORIES INC reads 60 out of 100 on Capital Returns Intelligence (Favorable Capital Returns), reflecting a share count falling about 1.8% a year. Direct capital returns are limited because the company continues reinvesting most of its cash. Capital Returns Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

What could go wrong

No weakening factors are recorded in today's stored readings, and data confidence is good. Absence of a recorded weakness is not evidence of safety.

Bottom line

No individual layer reaches the strongest band today. Separately from the score, valuation reads attractive at today's price.

Composite discovery model

Suggested Investment Score

Suggested Investment Score

80 / 100

Worth a Closer Look

A 0–100 composite discovery score combining Risk Intelligence, Long-Term Potential, Fundamental Momentum, and Ownership Intelligence. It helps rank qualified companies for further research and does not predict future returns.

Rank
#29 of 694
Percentile
Top 5%
Ranking updated
September 12, 2026
20Rank weakened by 20 positions. Rank weakened by 20 positions.
Risk Intelligence
79

30% contribution

Long-Term Potential
77

30% contribution

Fundamental Momentum
72

20% contribution

Ownership Intelligence
68

20% contribution

Ownership Intelligence

68 / 100 · Positive · 20% of the Suggested Investment Score

SUPPLEMENTAL / DESCRIPTIVE INTELLIGENCE

Coverage: Good

Elite Investor Activity
60 · Moderately Positive

50% of Ownership Intelligence · 10% of the total score

Tracked professional-manager activity is moderately positive.

Institutional Activity
88 · Strong

20% of Ownership Intelligence · 4% of the total score

Broad institutional evidence from resolved filings is strong.

Insider Activity
Insufficient Data

15% of Ownership Intelligence · 3% of the total score

No discretionary insider transactions are stored for this company, so this evidence is unavailable rather than neutral.

Strategic Ownership
Insufficient Data

15% of Ownership Intelligence · 3% of the total score

No qualifying major-holder filings are stored, so this evidence is unavailable rather than neutral.

Ownership Intelligence summarizes publicly disclosed activity among professional investment managers, broader institutions, company insiders, and significant strategic owners. It adds context to investment research but is not a validated predictor of future performance. Ownership information is publicly reported with a delay; the latest applicable reporting period is 2026-06-30, publicly disclosed 9/11/2026. Congressional activity is unavailable pending legal review and contributes nothing to this reading.

Why it ranks here

  • Strong risk profile

    Risk Intelligence ranks in the top 11% of qualified companies, with lower_risk price risk.

  • Exceptional long-term potential

    Stored profitability, capital efficiency and reinvestment readings rank near the top of the qualified universe.

  • Improving fundamentals

    Recent reported business trends rank among the strongest in the qualified universe.

What holds it back

  • Ownership evidence is not uniformly supportive

    The combined disclosed ownership evidence ranks below the qualified median.

  • Ownership evidence disagrees

    Different owner groups point in different directions, so the combined reading is best read as mixed rather than uniformly favourable.

COMPOSITE DISCOVERY MODEL — RESEARCH STAGE · Data coverage Excellent. Rankings are recalculated daily using the latest available information. Individual components may update at different frequencies based on when new financial and ownership data becomes available.

Researched separately

Valuation Intelligence 65 · Attractive

RESEARCH MODEL

Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.

Researched separately

Capital Returns Intelligence 60 · Favorable Capital Returns

RESEARCH MODEL

Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.

Score explanation

Why this company scores the way it does

Four research areas carry fixed weights. Each area is compared against every other eligible company, then weighted. The four contributions below add to 79.9 of the stored score (79.9).

  • Risk Intelligence

    30% of the score · contributes 26.9 points

    How strong and defensively sound is the company?

    Stands at the 90 percentile of eligible companies · stored reading 79 · 34% of this company’s total score

    How financially sturdy the company has been when conditions turned against it.

    How this area is measured

    Risk Intelligence reads stored balance-sheet strength, historical downside behaviour and the company's price-risk grouping. A stronger reading describes past resilience; it does not protect against future losses.

    Full methodology
  • Long-Term Potential

    30% of the score · contributes 28.9 points

    Does the business have the characteristics needed to create value over many years?

    Stands at the 96 percentile of eligible companies · stored reading 77 · 36% of this company’s total score

    Whether the business has the durable characteristics long-term owners look for.

    How this area is measured

    Long-Term Potential reads durability characteristics such as profitability consistency, cash generation and reinvestment capability over multiple reported periods.

    Full methodology
  • Fundamental Momentum

    20% of the score · contributes 17.4 points

    Is the underlying business getting stronger or weaker?

    Stands at the 87 percentile of eligible companies · stored reading 72 · 22% of this company’s total score

    Whether the reported business results have been getting stronger or weaker.

    How this area is measured

    Fundamental Momentum compares recent reported fundamentals with the company's own earlier periods, so improvement or deterioration is measured against its history rather than against a forecast.

    Full methodology
  • Ownership Intelligence

    20% of the score · contributes 6.7 points

    What are important owners actually doing?

    Stands at the 34 percentile of eligible companies · stored reading 68 · 8% of this company’s total score

    What large reporting owners have actually been doing with their positions.

    How this area is measured

    Ownership Intelligence reads public ownership filings: how many tracked reporting owners hold the company, and whether they were adding, holding, reducing or exiting in the latest disclosed period.

    Full methodology

What is helping the score

  • Long-Term Potential96 percentile, adding 28.9 points.
  • Risk Intelligence90 percentile, adding 26.9 points.
  • Fundamental Momentum87 percentile, adding 17.4 points.

What deserves attention

  • Ownership Intelligence34 percentile, adding only 6.7 of a possible 20 points.
Outside the score

Additional research — not currently included in the primary Suggested Investment Score.

  • Valuation IntelligenceIDEXX LABORATORIES INC reads 65 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and above comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value.
  • Capital Returns IntelligenceIDEXX LABORATORIES INC reads 60 out of 100 on Capital Returns Intelligence (Favorable Capital Returns), reflecting a share count falling about 1.8% a year. Direct capital returns are limited because the company continues reinvesting most of its cash.

Stored snapshots only

What changed

Research-score history available since September 2026.

Stored research history does not yet cover a full 30 days comparison for this company.

A change is reported as meaningful at 8 score points, 5 rank places, or any change of research classification. Nothing here is a recommendation to buy or sell.

Learn the metrics on this page

Plain-English definitions, with the formula and the limitations of each measure.

Fifth research lens · outside the score

Valuation Intelligence

Valuation Intelligence

Is today's price reasonable?

Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.

65/ 100

Attractive

RESEARCH MODEL
Excellent coverage

Compared with its history

92

Very Attractive

Is this company expensive or inexpensive compared with its own history?

Compared with peers

35

Elevated

How expensive is this stock compared with similar companies?

Earnings & cash flow

45

Elevated

How much financial output does an investor receive relative to the price paid?

Growth-adjusted

84

Very Attractive

Does the company's growth help justify the valuation investors are paying?

IDEXX LABORATORIES INC reads 65 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and above comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value.

Price data through September 11, 2026 · Financial data through the quarter ended June 30, 2026

Valuation history

Stored readings only. The dashed line is this company's own median for the selected measure.

Only one stored valuation reading exists so far, so there is nothing to chart yet. Valuation history builds forward from activation rather than being reconstructed.

Current P/E 34.9x · own median 55.5x · peer median 32.4x

Valuation is inherently uncertain. A stock that appears inexpensive can continue falling, and a stock that appears expensive can continue rising. Valuation Intelligence provides context about the price investors are paying — it does not predict short-term market movements, and it never produces a fair value, a price target or a buy or sell range. Model VALUATION_INTELLIGENCE_V1.

Sixth research lens · outside the score

Capital Returns Intelligence

Capital Returns Intelligence

How effectively does the company reward shareholders?

Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.

60/ 100

Favorable Capital Returns

RESEARCH MODEL
Excellent coverage

Dividend Quality

Not Applicable — No Dividend

Dividend reliability

This company currently retains rather than distributes cash through dividends. Capital Returns Intelligence therefore places more emphasis on its other measurable shareholder-return behaviors according to the frozen V1 methodology.

Buyback Effectiveness

71

Strong Capital Returns

Do buybacks actually reduce shares?

Dilution Control

66

Favorable Capital Returns

Is your ownership share protected?

Capital Return Sustainability

48

Moderate Capital Returns

Can the cash flow support it?

Shareholder Yield

48

Moderate Capital Returns

Cash returned versus company value

IDEXX LABORATORIES INC reads 60 out of 100 on Capital Returns Intelligence (Favorable Capital Returns), reflecting a share count falling about 1.8% a year. Direct capital returns are limited because the company continues reinvesting most of its cash.

This company currently retains rather than distributes cash through dividends. Capital Returns Intelligence therefore places more emphasis on its other measurable shareholder-return behaviors according to the frozen V1 methodology.

How returned cash was used

Dividends $0.00 · net repurchases $1.06B · total returned $1.06B · 85% of free cash flow

Price data through September 11, 2026 · Financial data through the quarter ended June 30, 2026

Capital returns history

Stored readings only. History builds forward from activation rather than being reconstructed.

Only one stored reading exists for this measure so far, so there is nothing to chart yet.

Why higher yield isn't always better

A very high dividend yield may reflect a falling share price or an unsustainable payout. Capital Returns Intelligence emphasizes consistency and sustainability rather than simply rewarding the highest yield.

Why buybacks can be misleading

Announced or gross buyback spending does not always mean shareholders are gaining ownership. Companies can simultaneously issue shares through employee compensation or acquisitions. Suggested Investments therefore considers actual share-count changes alongside repurchase spending.

What these terms mean
Dividend Yield
The annual dividend relative to the current share price.
Payout Ratio
The share of company earnings used to pay dividends.
Free Cash Flow Payout
How much of the company's available cash is being used for dividends.
Share Repurchases
When a company buys back its own stock.
Dilution
When the number of shares increases, reducing each existing share's percentage ownership of the company.
Shareholder Yield
A combined view of dividends and net share repurchases relative to the company's market value.

Capital Returns Intelligence describes how a company returns capital to shareholders. It is not a measure of stock-price performance, it does not predict future returns, and a strong reading is never a recommendation to buy. Dividends and repurchases can be reduced or stopped at any time. Model CAPITAL_RETURNS_INTELLIGENCE_V1, contributing 0% to the Suggested Investment Score.

Stored daily snapshots only

Ranking history

Stored Suggested Investment ranking history
Today#29Score 80
30 days agoNot rankedNo stored score
90 days agoNot rankedNo stored score
First suggestedSeptember 12, 2026
Highest rank#29

In the company’s own words

What this company does

, Marketing and Distribution" included in this Annual Report on Form 10-K for additional information regarding distribution channels.

Effects of Patent Expiration . Although certain patents and licenses of patents and technologies from third parties periodically expire, the expiration of these patents or licenses, individually or in the aggregate, is not expected to have a material effect on our financial position or future operations due to a range of factors as described in "Part I, Item 1. Intellectual Property, Including Patents and License."

Non-GAAP Financial Measures . The following revenue analysis and discussion includes organic revenue growth, and references in this analysis and discussion to "revenue," "revenues," or "revenue growth" apply equally to revenue growth reported in accordance with U.S. GAAP and to "organic revenue growth." Organic revenue growth is a non-GAAP financial measure and represents the percentage change in revenue during the current year, compared to the same period for the prior year, net of the effect of changes in foreign currency exchange rates, certain business acquisitions, and divestitures. Organic revenue growth should be considered in addition to, and not as a replacement for, or as a superior measure to, revenue growth reported in accordance with U.S. GAAP, and may not be comparable to similarly titled measures reported by other companies. Management believes that reporting organic revenue growth provides useful information to investors by facilitating easier comparisons of our revenue performance with prior and future periods and to the performance of our peers.

We exclude from organic revenue growth the effect of changes in foreign currency exchange rates because changes in foreign currency exchange rates are not under management’s control, are subject to volatility, and can obscure underlying business trends. We calculate the impact on revenue resulting from changes in foreign currency exchange rates by applying the difference between the weighted average exchange rates during the current period and the comparable prior year period to foreign currency denominated revenues for the prior year period.

Quoted from the business section of this company’s 10-K filed February 20, 2026. Read the filing

Four distinct intelligence areas

The IA view

Risk Intelligence

Production core

79

Fundamentally Qualified

-7.3 vs Jun 30, 2026

Business Quality qualification score from the locked IA Defensive Research Core. Price Risk stays a separate category and is never blended in.

As of Sep 11, 2026

Long-Term Potential

Research model

77

Elite Compounder

+35.5 vs Jun 30, 2026

Durable business economics and reinvestment characteristics. Independent external validation is pending.

As of Sep 11, 2026

Fundamental Momentum

Research model

72

Accelerating

+16.3 vs Jun 30, 2026

Direction and breadth of change in underlying business fundamentals. Not a price-momentum signal.

As of Sep 11, 2026

Elite Investor Activity

Supplemental

60

Mid range

0 vs Jun 30, 2026

Only 5 tracked managers disclosed a position — treat as limited coverage.

As of Sep 11, 2026

Company intelligence

IDXX score history

Each area is measured and reported separately. No combined score exists.

IDXX intelligence history from 2023-09-30 to 2026-09-11. Risk Intelligence 78.5 on 2026-09-11, down 7.3 from 85.8 on 2026-06-30. Long-Term Potential 76.7 on 2026-09-11, up 35.5 from 41.2 on 2026-06-30. Fundamental Momentum 72.3 on 2026-09-11, up 16.3 from 56 on 2026-06-30. Elite Investor Activity 60 on 2026-09-11, unchanged 0 from 60 on 2026-06-30. Each area is reported separately and is never combined into a single score.

Risk Intelligence 78.5 as of Sep 11, 2026 (-7.3 vs prior period) · Production core

Long-Term Potential 76.7 as of Sep 11, 2026 (+35.5 vs prior period) · Research model

Fundamental Momentum 72.3 as of Sep 11, 2026 (+16.3 vs prior period) · Research model

Elite Investor Activity 60 as of Sep 11, 2026 (0 vs prior period) · Supplemental

Share price

IDXX price history

Closing prices adjusted for splits and dividends. Past prices do not indicate future results.

6M change
-11.6%
1Y change
-21.8%
3Y change
+10.1%
5Y change
-23.9%
Max change
+90.4%

Last stored close $504.70 · -21.8% over the selected range · 52 sessions shown

Balanced evidence

Why IA likes it

  • Business Quality meets the frozen IA Defensive qualification.
  • More disclosed holders are new or increasing than reducing or exiting.

Risk and uncertainty

What IA doesn’t like

  • No specific negative evidence is available. This is not evidence of low risk.

What would change our view

  • Business Quality falling below the frozen qualification threshold.
  • Price Risk moving to a less favorable category.
  • A sustained reversal in the Fundamental Momentum research evidence.
  • New material public ownership disclosures.

Public filings · descriptive only

Elite Investor Activity

Reporting holders

13

New holders

10

Increasing

0

Reducing

2

Exiting

0

Coverage

Excellent

Positive disclosed activity · Report period 2022-12-31 · Public 12/19/2023

ManagerChangePortfolio weightRankDisclosed

Insufficient high-confidence manager coverage.

Objective stored changes

What changed

  • Risk Intelligence

    IA Defensive weakened

    Business Quality qualification score moved from 85.8 to 82.7.

  • Risk Intelligence

    Price Risk category changed

    Price Risk moved from Not Available to Normal risk.

  • Long-Term Potential

    IA Compounder strengthened

    IA Compounder research score moved from 41.2 to 70.1.

  • Fundamental Momentum

    Fundamental Momentum improved

    Fundamental Momentum research score moved from 56.0 to 75.9.

  • Long-Term Potential

    IA Compounder softened

    IA Compounder research score moved from 70.1 to 41.2.

  • Fundamental Momentum

    Fundamental Momentum softened

    Fundamental Momentum research score moved from 76.2 to 56.0.

  • Elite Investor Activity

    Elite Investor Consensus strengthened

    Disclosed agreement among tracked managers moved from 17 to 60 for the reporting period ending 2026-06-30.

  • Elite Investor Activity

    Elite Investor Consensus weakened

    Disclosed agreement among tracked managers moved from 50 to 17 for the reporting period ending 2026-03-31.

  • Elite Investor Activity

    Tracked managers exited positions

    2 tracked managers no longer disclosed a position for the reporting period ending 2026-03-31.

  • Elite Investor Activity

    Tracked managers initiated positions

    2 tracked managers first disclosed a position for the reporting period ending 2025-12-31.

Ownership timeline

No high-confidence public ownership events are available.

General research only. Not personalized advice. Public filings may be delayed, amended, incomplete, or reflect positions that have changed since the reporting date.